"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms ...

For people with chronic skin conditions, telehealth altered how they care for their skin and their bodies by removing ...

The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...

About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...

Johnson & Johnson (JNJ) stock is in focus as US approves its once-daily pill Icotyde developed with Protagonist Therapeutics ...

The clearance is the first for an oral peptide that blocks IL-23, the target of popular medicines like Skyrizi and Tremfya. J ...

This is the first IL-23 receptor-targeted oral peptide pill, and it is also being evaluated as a treatment for psoriatic ...

"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...

While certain skin conditions such as acne can seem easy to diagnose from home, others can be a bit trickier, like eczema and psoriasis. These two skin conditions, which usually present themselves in ...

A whopping 125 million people worldwide are living with psoriasis, so you'd think there would be more comprehensive info out there about it. Unfortunately, nope. There's still plenty of ...

Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...

A recent study published in eBioMedicine performed a multi-omics analysis of host-microbe interactions in psoriasis. Study: Exploratory multi-omics analysis reveals host-microbe interactions ...